-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
As SARS-CoV-2 continues to spread and mutate, it is important to determine new treatment options
Molnupiravir was originally used to treat influenza.
John McIntosh, Patrick Fier and colleagues of Merck and Codexis set out to develop a shorter, more productive, and sustainable way to synthesize this molecule
Researchers have developed a three-step synthesis method to synthesize Molnupiravir from a sugar molecule called ribose
The author of the research report admitted that the funding came from Merck Sharp & Dohme Corp
10.